Skip to main content
Erschienen in:

01.06.2011 | REVIEW

Glucose Metabolism Disorders and the Risk of Cancer

verfasst von: Paweł Piątkiewicz, Anna Czech

Erschienen in: Archivum Immunologiae et Therapiae Experimentalis | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Diabetes and cancer are diseases which take the size of an epidemic spread across the globe. Those diseases are influenced by many factors, both genetic and environmental. Precise knowledge of the complex relationships and interactions between these two conditions is of great importance for their prevention and treatment. Many epidemiological studies have shown that certain types of cancer, especially gastrointestinal cancers (pancreas, liver, colon) and also the urinary and reproductive system cancers in women are more common in patients with diabetes or related metabolic disorders. There are also studies showing the inverse relationship between diabetes and cancer, or the lack of it, but they are less numerous and relate mainly to prostate cancer or squamous cell carcinoma of the esophagus. Epidemiological studies, however, do not say anything about the mechanisms of these dependencies. For this purpose, molecular research is needed on the metabolism of cells (including tumor cells) and on metabolic dysfunctions that arise due to changes in the cell environment taking place in the sick, as well as in the intensely treated human organism.
Literatur
Zurück zum Zitat Adami HO, Chow WH, Nyrén O et al (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88:1472–1477PubMed Adami HO, Chow WH, Nyrén O et al (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88:1472–1477PubMed
Zurück zum Zitat Ahn J, Weinstein SJ, Snyder K et al (2006) No association between serum insulin-like growth factor (IGF)-I, IGF-binding protein-3, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 15:2010–2012PubMed Ahn J, Weinstein SJ, Snyder K et al (2006) No association between serum insulin-like growth factor (IGF)-I, IGF-binding protein-3, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 15:2010–2012PubMed
Zurück zum Zitat Airley RE, Mobasheri A (2007) Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 53:233–256PubMed Airley RE, Mobasheri A (2007) Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 53:233–256PubMed
Zurück zum Zitat Alexiou P, Chatzopoulou M, Pegklidou K et al (2010) RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr Med Chem 17:2232–2252PubMed Alexiou P, Chatzopoulou M, Pegklidou K et al (2010) RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr Med Chem 17:2232–2252PubMed
Zurück zum Zitat Atchison EA, Gridley G, Carreon JD et al (2011) Risk of cancer in a large cohort of US veterans with diabetes. Int J Cancer 128:635–643PubMed Atchison EA, Gridley G, Carreon JD et al (2011) Risk of cancer in a large cohort of US veterans with diabetes. Int J Cancer 128:635–643PubMed
Zurück zum Zitat Balato A, Unutmaz D, Gaspari AA (2009) Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J Invest Dermatol 129:1628–1642PubMed Balato A, Unutmaz D, Gaspari AA (2009) Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J Invest Dermatol 129:1628–1642PubMed
Zurück zum Zitat Balkau B, Kahn HS, Courbon D et al (2001) Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: the Paris Prospective Study. Diabetes Care 24:843–849PubMed Balkau B, Kahn HS, Courbon D et al (2001) Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: the Paris Prospective Study. Diabetes Care 24:843–849PubMed
Zurück zum Zitat Barbarroja N, Lopez-Pedrera R, Mayas MD et al (2010) The obese healthy paradox: is inflammation the answer? Biochem J 430:141–149PubMed Barbarroja N, Lopez-Pedrera R, Mayas MD et al (2010) The obese healthy paradox: is inflammation the answer? Biochem J 430:141–149PubMed
Zurück zum Zitat Barone BB, Yeh HC, Snyder CF et al (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300:2754–2764PubMed Barone BB, Yeh HC, Snyder CF et al (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300:2754–2764PubMed
Zurück zum Zitat Barone BB, Yeh HC, Snyder CF et al (2010) Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care 33:931–939PubMed Barone BB, Yeh HC, Snyder CF et al (2010) Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care 33:931–939PubMed
Zurück zum Zitat Bendelac A, Savage PB, Teyton L (2007) The biology of NKT cells. Annu Rev Immunol 25:297–336PubMed Bendelac A, Savage PB, Teyton L (2007) The biology of NKT cells. Annu Rev Immunol 25:297–336PubMed
Zurück zum Zitat Bergamini E, Cavallini G, Donati A et al (2007) The role of autophagy in aging: its essential part in the anti-aging mechanism of caloric restriction. Ann NY Acad Sci 1114:69–78PubMed Bergamini E, Cavallini G, Donati A et al (2007) The role of autophagy in aging: its essential part in the anti-aging mechanism of caloric restriction. Ann NY Acad Sci 1114:69–78PubMed
Zurück zum Zitat Berzofsky JA, Terabe M (2009) The contrasting roles of NKT cells in tumor immunity. Curr Mol Med 9:667–672PubMed Berzofsky JA, Terabe M (2009) The contrasting roles of NKT cells in tumor immunity. Curr Mol Med 9:667–672PubMed
Zurück zum Zitat Biassoni R (2009) Human natural killer receptors, co-receptors, and their ligands. Curr Protoc Immunol Chapter 14:Unit 14.10 Biassoni R (2009) Human natural killer receptors, co-receptors, and their ligands. Curr Protoc Immunol Chapter 14:Unit 14.10
Zurück zum Zitat Blüher M (2009) Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 117:241–250PubMed Blüher M (2009) Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 117:241–250PubMed
Zurück zum Zitat Blüher M (2010) The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol 21:38–43PubMed Blüher M (2010) The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol 21:38–43PubMed
Zurück zum Zitat Boden G (2009) Endoplasmic reticulum stress: another link between obesity and insulin resistance/inflammation? Diabetes 58:518–519PubMed Boden G (2009) Endoplasmic reticulum stress: another link between obesity and insulin resistance/inflammation? Diabetes 58:518–519PubMed
Zurück zum Zitat Borugian MJ, Spinelli JJ, Sun Z et al (2007) Prediagnostic C-peptide and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 16:2164–2165PubMed Borugian MJ, Spinelli JJ, Sun Z et al (2007) Prediagnostic C-peptide and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 16:2164–2165PubMed
Zurück zum Zitat Boulle N, Logié A, Gicquel C et al (1998) Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors. J Clin Endocrinol Metab 83:1713–1720PubMed Boulle N, Logié A, Gicquel C et al (1998) Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors. J Clin Endocrinol Metab 83:1713–1720PubMed
Zurück zum Zitat Bowker SL, Majumdar SR, Veugelers P (2006) Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 29:254–258PubMed Bowker SL, Majumdar SR, Veugelers P (2006) Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 29:254–258PubMed
Zurück zum Zitat Bowker SL, Yasui Y, Veugelers P et al (2010) Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure. Diabetologia 53:1631–1637PubMed Bowker SL, Yasui Y, Veugelers P et al (2010) Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure. Diabetologia 53:1631–1637PubMed
Zurück zum Zitat Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625PubMed Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625PubMed
Zurück zum Zitat Bustamante E, Morris HP, Pedersen PL (1981) Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem 256:8699–8704PubMed Bustamante E, Morris HP, Pedersen PL (1981) Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem 256:8699–8704PubMed
Zurück zum Zitat Buzzai M, Jones RG, Amaravadi RK et al (2007) Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 67:6745–6752PubMed Buzzai M, Jones RG, Amaravadi RK et al (2007) Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 67:6745–6752PubMed
Zurück zum Zitat Cai W, He JC, Zhu L et al (2004) High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients. Circulation 110:285–291PubMed Cai W, He JC, Zhu L et al (2004) High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients. Circulation 110:285–291PubMed
Zurück zum Zitat Cannata D, Fierz Y, Vijayakumar A et al (2010) Type 2 diabetes and cancer: what is the connection? Mt Sinai J Med 77:197–213PubMed Cannata D, Fierz Y, Vijayakumar A et al (2010) Type 2 diabetes and cancer: what is the connection? Mt Sinai J Med 77:197–213PubMed
Zurück zum Zitat Chan AC, Serwecinska L, Cochrane A et al (2009) Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family. Clin Exp Immunol 156:238–245PubMed Chan AC, Serwecinska L, Cochrane A et al (2009) Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family. Clin Exp Immunol 156:238–245PubMed
Zurück zum Zitat Chodick G, Heymann AD, Rosenmann L et al (2010) Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control 21:879–887PubMed Chodick G, Heymann AD, Rosenmann L et al (2010) Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control 21:879–887PubMed
Zurück zum Zitat Chong CR, Chabner BA (2009) Mysterious metformin. Oncologist 14:1178–1181PubMed Chong CR, Chabner BA (2009) Mysterious metformin. Oncologist 14:1178–1181PubMed
Zurück zum Zitat Christofk HR, Vander Heiden MG, Harris MH et al (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230–233PubMed Christofk HR, Vander Heiden MG, Harris MH et al (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230–233PubMed
Zurück zum Zitat Colhoun HM (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52:1755–1765PubMed Colhoun HM (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52:1755–1765PubMed
Zurück zum Zitat Colotta F, Allavena P, Sica A et al (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30:1073–1081PubMed Colotta F, Allavena P, Sica A et al (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30:1073–1081PubMed
Zurück zum Zitat Considine RV, Sinha MK, Heiman ML et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292–295PubMed Considine RV, Sinha MK, Heiman ML et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292–295PubMed
Zurück zum Zitat Corleta HE, Capp E, Corleta OC (1996) Insulin receptor tyrosine kinase activity in colon carcinoma. Braz J Med Biol Res 29:1593–1597PubMed Corleta HE, Capp E, Corleta OC (1996) Insulin receptor tyrosine kinase activity in colon carcinoma. Braz J Med Biol Res 29:1593–1597PubMed
Zurück zum Zitat Coughlin SS, Calle EE, Teras LR et al (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160–1167PubMed Coughlin SS, Calle EE, Teras LR et al (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160–1167PubMed
Zurück zum Zitat Courtney KD, Corcoran RB, Engelman JA (2010) The PI3K pathway as drug target in human cancer. J Clin Oncol 28:1075–1083PubMed Courtney KD, Corcoran RB, Engelman JA (2010) The PI3K pathway as drug target in human cancer. J Clin Oncol 28:1075–1083PubMed
Zurück zum Zitat Currie CJ, Poole CD, Gale EA (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52:1766–1777PubMed Currie CJ, Poole CD, Gale EA (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52:1766–1777PubMed
Zurück zum Zitat Cust AE, Allen NE, Kaaks R et al (2007) Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. Int J Cancer 120:2656–2664PubMed Cust AE, Allen NE, Kaaks R et al (2007) Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. Int J Cancer 120:2656–2664PubMed
Zurück zum Zitat De Meyts P (1994) The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 37(suppl 2):S135–S148PubMed De Meyts P (1994) The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 37(suppl 2):S135–S148PubMed
Zurück zum Zitat DeBerardinis RJ, Mancuso A, Daikhin E et al (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 104:19345–19350PubMed DeBerardinis RJ, Mancuso A, Daikhin E et al (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 104:19345–19350PubMed
Zurück zum Zitat DeBerardinis RJ, Lum JJ, Hatzivassiliou G et al (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7:11–20PubMed DeBerardinis RJ, Lum JJ, Hatzivassiliou G et al (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7:11–20PubMed
Zurück zum Zitat Dejgaard A, Lynggaard H, Råstam J et al (2009) No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis. Diabetologia 52:2507–2512PubMed Dejgaard A, Lynggaard H, Råstam J et al (2009) No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis. Diabetologia 52:2507–2512PubMed
Zurück zum Zitat Díez JJ, Iglesias P (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148:293–300PubMed Díez JJ, Iglesias P (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148:293–300PubMed
Zurück zum Zitat Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK et al (2010) Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 33:55–60PubMed Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK et al (2010) Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 33:55–60PubMed
Zurück zum Zitat Eliassen AH, Tworoger SS, Mantzoros CS et al (2007) Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev 16:161–164PubMed Eliassen AH, Tworoger SS, Mantzoros CS et al (2007) Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev 16:161–164PubMed
Zurück zum Zitat El-Shewy HM, Luttrell LM (2009) Insulin-like growth factor-2/mannose-6 phosphate receptors. Vitam Horm 80:667–697PubMed El-Shewy HM, Luttrell LM (2009) Insulin-like growth factor-2/mannose-6 phosphate receptors. Vitam Horm 80:667–697PubMed
Zurück zum Zitat Feng YH, Velazquez-Torres G, Gully C et al (2010) The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. J Cell Mol Med [Epub ahead of print] Feng YH, Velazquez-Torres G, Gully C et al (2010) The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. J Cell Mol Med [Epub ahead of print]
Zurück zum Zitat Flood A, Strayer L, Schairer C et al (2010) Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control 21:1277–1284PubMed Flood A, Strayer L, Schairer C et al (2010) Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control 21:1277–1284PubMed
Zurück zum Zitat Frasca F, Pandini G, Sciacca L et al (2008) The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem 114:23–37PubMed Frasca F, Pandini G, Sciacca L et al (2008) The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem 114:23–37PubMed
Zurück zum Zitat Friberg E, Orsini N, Mantzoros CS et al (2007) Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50:1365–1374PubMed Friberg E, Orsini N, Mantzoros CS et al (2007) Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50:1365–1374PubMed
Zurück zum Zitat Furue H, Matsuo K, Kumimoto H et al (2008) Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese. Carcinogenesis 29:316–320PubMed Furue H, Matsuo K, Kumimoto H et al (2008) Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese. Carcinogenesis 29:316–320PubMed
Zurück zum Zitat Garofalo C, Surmacz E (2006) Leptin and cancer. J Cell Physiol 207:12–22PubMed Garofalo C, Surmacz E (2006) Leptin and cancer. J Cell Physiol 207:12–22PubMed
Zurück zum Zitat Gebhardt C, Riehl A, Durchdewald M et al (2008) RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 205:275–285PubMed Gebhardt C, Riehl A, Durchdewald M et al (2008) RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 205:275–285PubMed
Zurück zum Zitat Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60:207–221PubMed Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60:207–221PubMed
Zurück zum Zitat Godsland IF (2009) Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci 118:315–332PubMed Godsland IF (2009) Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci 118:315–332PubMed
Zurück zum Zitat Goldberg T, Cai W, Peppa M et al (2004) Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 104:1287–1291PubMed Goldberg T, Cai W, Peppa M et al (2004) Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 104:1287–1291PubMed
Zurück zum Zitat Gonzalez-Angulo AM, Meric-Bernstam F (2010) Metformin: a therapeutic opportunity in breast cancer. Clin Cancer Res 16:1695–1700PubMed Gonzalez-Angulo AM, Meric-Bernstam F (2010) Metformin: a therapeutic opportunity in breast cancer. Clin Cancer Res 16:1695–1700PubMed
Zurück zum Zitat Górska E, Popko K, Winiarska M et al (2009) [Pleiotropic effects of leptin] (in Polish). Pediatr Endocrinol Diabetes Metab 15:45–50PubMed Górska E, Popko K, Winiarska M et al (2009) [Pleiotropic effects of leptin] (in Polish). Pediatr Endocrinol Diabetes Metab 15:45–50PubMed
Zurück zum Zitat Grote VA, Becker S, Kaaks R (2010) Diabetes mellitus type 2—an independent risk factor for cancer? Exp Clin Endocrinol Diabetes 118:4–8PubMed Grote VA, Becker S, Kaaks R (2010) Diabetes mellitus type 2—an independent risk factor for cancer? Exp Clin Endocrinol Diabetes 118:4–8PubMed
Zurück zum Zitat Hall GC, Roberts CM, Boulis M et al (2005) Diabetes and the risk of lung cancer. Diabetes Care 28:590–594PubMed Hall GC, Roberts CM, Boulis M et al (2005) Diabetes and the risk of lung cancer. Diabetes Care 28:590–594PubMed
Zurück zum Zitat Hammond KJ, Pelikan SB, Crowe NY et al (1999) NKT cells are phenotypically and functionally diverse. Eur J Immunol 29:3768–3781PubMed Hammond KJ, Pelikan SB, Crowe NY et al (1999) NKT cells are phenotypically and functionally diverse. Eur J Immunol 29:3768–3781PubMed
Zurück zum Zitat Hayashi T, Tsujii S, Iburi T et al (2007) Laughter up-regulates the genes related to NK cell activity in diabetes. Biomed Res 28:281–285PubMed Hayashi T, Tsujii S, Iburi T et al (2007) Laughter up-regulates the genes related to NK cell activity in diabetes. Biomed Res 28:281–285PubMed
Zurück zum Zitat Hébert E (2006) Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development. Biosci Rep 26:7–17PubMed Hébert E (2006) Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development. Biosci Rep 26:7–17PubMed
Zurück zum Zitat Hemkens LG, Grouven U, Bender R et al (2009) Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 52:1732–1744PubMed Hemkens LG, Grouven U, Bender R et al (2009) Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 52:1732–1744PubMed
Zurück zum Zitat Hemminki K, Li X, Sundquist J et al (2010) Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15:548–555PubMed Hemminki K, Li X, Sundquist J et al (2010) Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15:548–555PubMed
Zurück zum Zitat Hermann C, Assmus B, Urbich C et al (2000) Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells. Arterioscler Thromb Vasc Biol 20:402–409PubMed Hermann C, Assmus B, Urbich C et al (2000) Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells. Arterioscler Thromb Vasc Biol 20:402–409PubMed
Zurück zum Zitat Hirose K, Toyama T, Iwata H et al (2003) Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women. Asian Pac J Cancer Prev 4:239–246PubMed Hirose K, Toyama T, Iwata H et al (2003) Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women. Asian Pac J Cancer Prev 4:239–246PubMed
Zurück zum Zitat Hitosugi T, Kang S, Vander Heiden MG et al (2009) Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2:ra73 Hitosugi T, Kang S, Vander Heiden MG et al (2009) Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2:ra73
Zurück zum Zitat Holly J, Perks C (2006) The role of insulin-like growth factor binding proteins. Neuroendocrinology 83:154–160PubMed Holly J, Perks C (2006) The role of insulin-like growth factor binding proteins. Neuroendocrinology 83:154–160PubMed
Zurück zum Zitat Home PD, Lagarenne P (2009) Combined randomised controlled trial experience of malignancies in studies using insulin glargine. Diabetologia 52:2499–2506PubMed Home PD, Lagarenne P (2009) Combined randomised controlled trial experience of malignancies in studies using insulin glargine. Diabetologia 52:2499–2506PubMed
Zurück zum Zitat Houseknecht KL, Baile CA, Matteri RL et al (1998) The biology of leptin: a review. J Anim Sci 76:1405–1420PubMed Houseknecht KL, Baile CA, Matteri RL et al (1998) The biology of leptin: a review. J Anim Sci 76:1405–1420PubMed
Zurück zum Zitat Hudelist G, Wagner T, Rosner M et al (2007) Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations. Endocr Relat Cancer 14:1053–1062PubMed Hudelist G, Wagner T, Rosner M et al (2007) Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations. Endocr Relat Cancer 14:1053–1062PubMed
Zurück zum Zitat Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A et al (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076–2083PubMed Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A et al (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076–2083PubMed
Zurück zum Zitat Hwa V, Oh Y, Rosenfeld RG (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20:761–787PubMed Hwa V, Oh Y, Rosenfeld RG (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20:761–787PubMed
Zurück zum Zitat Ihle NT, Powis G (2009) Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy. Mol Cancer Ther 8:1–9PubMed Ihle NT, Powis G (2009) Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy. Mol Cancer Ther 8:1–9PubMed
Zurück zum Zitat Inoue M, Iwasaki M, Otani T et al (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:1871–1877PubMed Inoue M, Iwasaki M, Otani T et al (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:1871–1877PubMed
Zurück zum Zitat Jamal MM, Yoon EJ, Vega KJ et al (2009) Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol 15:5274–5278PubMed Jamal MM, Yoon EJ, Vega KJ et al (2009) Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol 15:5274–5278PubMed
Zurück zum Zitat Jee SH, Ohrr H, Sull JW (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194–202PubMed Jee SH, Ohrr H, Sull JW (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194–202PubMed
Zurück zum Zitat Jenab M, Riboli E, Cleveland RJ et al (2007) Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 121:368–376PubMed Jenab M, Riboli E, Cleveland RJ et al (2007) Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 121:368–376PubMed
Zurück zum Zitat Jensen M, De Meyts P (2009) Molecular mechanisms of differential intracellular signaling from the insulin receptor. Vitam Horm 80:51–75PubMed Jensen M, De Meyts P (2009) Molecular mechanisms of differential intracellular signaling from the insulin receptor. Vitam Horm 80:51–75PubMed
Zurück zum Zitat Jerud ES, Bricard G, Porcelli SA (2006) CD1d-restricted natural killer t cells: roles in tumor immunosurveillance and tolerance. Transfus Med Hemother 33:18–36 Jerud ES, Bricard G, Porcelli SA (2006) CD1d-restricted natural killer t cells: roles in tumor immunosurveillance and tolerance. Transfus Med Hemother 33:18–36
Zurück zum Zitat Jonasson JM, Ljung R, Talbäck M et al (2009) Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia 52:1745–1754PubMed Jonasson JM, Ljung R, Talbäck M et al (2009) Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia 52:1745–1754PubMed
Zurück zum Zitat Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34PubMed Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34PubMed
Zurück zum Zitat Joshi N, Caputo GM, Weitekamp MR (1999) Infections in patients with diabetes mellitus. N Engl J Med 341:1906–1912PubMed Joshi N, Caputo GM, Weitekamp MR (1999) Infections in patients with diabetes mellitus. N Engl J Med 341:1906–1912PubMed
Zurück zum Zitat Kaaks R, Toniolo P, Akhmedkhanov A et al (2000) Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92:1592–1600PubMed Kaaks R, Toniolo P, Akhmedkhanov A et al (2000) Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92:1592–1600PubMed
Zurück zum Zitat Kasper JS, Giovanucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15:2056–2062PubMed Kasper JS, Giovanucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15:2056–2062PubMed
Zurück zum Zitat Kasper JS, Liu Y, Giovannucci E (2009) Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 124:1398–1403PubMed Kasper JS, Liu Y, Giovannucci E (2009) Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 124:1398–1403PubMed
Zurück zum Zitat Keinan-Boker L, Bueno De Mesquita HB, Kaaks R et al (2003) Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer. Int J Cancer 106:90–95PubMed Keinan-Boker L, Bueno De Mesquita HB, Kaaks R et al (2003) Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer. Int J Cancer 106:90–95PubMed
Zurück zum Zitat Kellerer M, von Eye Corleta H, Mühlhöfer A et al (1995) Insulin- and insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma. Int J Cancer 62:501–507PubMed Kellerer M, von Eye Corleta H, Mühlhöfer A et al (1995) Insulin- and insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma. Int J Cancer 62:501–507PubMed
Zurück zum Zitat Key TJ, Spencer EA, Reeves GK (2010) Symposium 1: overnutrition: consequences and solutions. Obesity and cancer risk. Proc Nutr Soc 69:86–90PubMed Key TJ, Spencer EA, Reeves GK (2010) Symposium 1: overnutrition: consequences and solutions. Obesity and cancer risk. Proc Nutr Soc 69:86–90PubMed
Zurück zum Zitat Kiessling R, Klein E, Pross H et al (1975) “Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 5:117–121PubMed Kiessling R, Klein E, Pross H et al (1975) “Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 5:117–121PubMed
Zurück zum Zitat Kiessling R, Petranyi G, Kärre K et al (1976) Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems. J Exp Med 143:772–780PubMed Kiessling R, Petranyi G, Kärre K et al (1976) Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems. J Exp Med 143:772–780PubMed
Zurück zum Zitat Kim JW, Dang CV (2006) Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res 66:8927–8930PubMed Kim JW, Dang CV (2006) Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res 66:8927–8930PubMed
Zurück zum Zitat Kim WY, Jin Q, Oh SH et al (2009) Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development. Cancer Res 69:7439–7448PubMed Kim WY, Jin Q, Oh SH et al (2009) Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development. Cancer Res 69:7439–7448PubMed
Zurück zum Zitat Kisfalvi K, Eibl G, Sinnett-Smith J (2009) Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Res 69:6539–6545PubMed Kisfalvi K, Eibl G, Sinnett-Smith J (2009) Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Res 69:6539–6545PubMed
Zurück zum Zitat Kurtzhals P, Schäffer L, Sørensen A et al (2000) Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49:999–1005PubMed Kurtzhals P, Schäffer L, Sørensen A et al (2000) Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49:999–1005PubMed
Zurück zum Zitat Landman GW, Ubink-Veltmaat LJ, Kleefstra N et al (2008) Increased cancer mortality in type 2 diabetes (ZODIAC-3). Anticancer Res 28:1373–1375PubMed Landman GW, Ubink-Veltmaat LJ, Kleefstra N et al (2008) Increased cancer mortality in type 2 diabetes (ZODIAC-3). Anticancer Res 28:1373–1375PubMed
Zurück zum Zitat Landman GW, Kleefstra N, van Hateren KJ et al (2010a) Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care 33:322–326PubMed Landman GW, Kleefstra N, van Hateren KJ et al (2010a) Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care 33:322–326PubMed
Zurück zum Zitat Landman GW, Van Hateren KJ, Kleefstra N et al (2010b) The relationship between obesity and cancer mortality in type 2 diabetes: a ten-year follow-up study (ZODIAC-21). Anticancer Res 30:681–682PubMed Landman GW, Van Hateren KJ, Kleefstra N et al (2010b) The relationship between obesity and cancer mortality in type 2 diabetes: a ten-year follow-up study (ZODIAC-21). Anticancer Res 30:681–682PubMed
Zurück zum Zitat Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97:1679–1687PubMed Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97:1679–1687PubMed
Zurück zum Zitat Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856–862PubMed Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856–862PubMed
Zurück zum Zitat Le Marchand L, Wang H, Rinaldi S et al (2010) Associations of plasma C-peptide and IGFBP-1 levels with risk of colorectal adenoma in a multiethnic population. Cancer Epidemiol Biomarkers Prev 19:1471–1477PubMed Le Marchand L, Wang H, Rinaldi S et al (2010) Associations of plasma C-peptide and IGFBP-1 levels with risk of colorectal adenoma in a multiethnic population. Cancer Epidemiol Biomarkers Prev 19:1471–1477PubMed
Zurück zum Zitat Lee PD, Giudice LC, Conover CA (1997) Insulin-like growth factor binding protein-1 recent findings and new directions. Proc Soc Exp Biol Med 216:319–357PubMed Lee PD, Giudice LC, Conover CA (1997) Insulin-like growth factor binding protein-1 recent findings and new directions. Proc Soc Exp Biol Med 216:319–357PubMed
Zurück zum Zitat Lee JS, Weiss J, Martin JL et al (2003) Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo. Int J Cancer 107:564–570PubMed Lee JS, Weiss J, Martin JL et al (2003) Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo. Int J Cancer 107:564–570PubMed
Zurück zum Zitat LeRoith D, Roberts CT Jr (2003) The insulin-like growth factor system and cancer. Cancer Lett 195:127–137PubMed LeRoith D, Roberts CT Jr (2003) The insulin-like growth factor system and cancer. Cancer Lett 195:127–137PubMed
Zurück zum Zitat Li D, Yeung SC, Hassan MM et al (2009) Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 137:482–488PubMed Li D, Yeung SC, Hassan MM et al (2009) Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 137:482–488PubMed
Zurück zum Zitat Li Q, Kobayashi M, Inagaki H et al (2010) A day trip to a forest park increases human natural killer activity and the expression of anti-cancer proteins in male subjects. J Biol Regul Homeost Agents 24:157–165PubMed Li Q, Kobayashi M, Inagaki H et al (2010) A day trip to a forest park increases human natural killer activity and the expression of anti-cancer proteins in male subjects. J Biol Regul Homeost Agents 24:157–165PubMed
Zurück zum Zitat Libby G, Donnelly LA, Donnan PT et al (2009) New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 32:1620–1625PubMed Libby G, Donnelly LA, Donnan PT et al (2009) New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 32:1620–1625PubMed
Zurück zum Zitat London SJ, Yuan JM, Travlos GS et al (2002) Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China. J Natl Cancer Inst 94:749–754PubMed London SJ, Yuan JM, Travlos GS et al (2002) Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China. J Natl Cancer Inst 94:749–754PubMed
Zurück zum Zitat Lowry F (2010) Novel ultra long-acting insulin as effective as insulin glargine. Presented at the American Diabetes Association (ADA) 70th Scientific Sessions: Abstract 34-OR, Orlando (Florida), June 25, 2010 Lowry F (2010) Novel ultra long-acting insulin as effective as insulin glargine. Presented at the American Diabetes Association (ADA) 70th Scientific Sessions: Abstract 34-OR, Orlando (Florida), June 25, 2010
Zurück zum Zitat Lukanova A, Toniolo P, Akhmedkhanov A et al (2001) A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women. Int J Cancer 92:888–892PubMed Lukanova A, Toniolo P, Akhmedkhanov A et al (2001) A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women. Int J Cancer 92:888–892PubMed
Zurück zum Zitat Lukanova A, Lundin E, Micheli A et al (2003) Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy). Cancer Causes Control 14:285–292PubMed Lukanova A, Lundin E, Micheli A et al (2003) Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy). Cancer Causes Control 14:285–292PubMed
Zurück zum Zitat Lukanova A, Zeleniuch-Jacquotte A, Lundin E et al (2004) Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer 108:262–268PubMed Lukanova A, Zeleniuch-Jacquotte A, Lundin E et al (2004) Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer 108:262–268PubMed
Zurück zum Zitat Lynch L, O’Shea D, Winter DC et al (2009a) Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur J Immunol 39:1893–1901PubMed Lynch L, O’Shea D, Winter DC et al (2009a) Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur J Immunol 39:1893–1901PubMed
Zurück zum Zitat Lynch LA, O’Connell JM, Kwasnik AK et al (2009b) Are natural killer cells protecting the metabolically healthy obese patient? Obesity 17:601–605PubMed Lynch LA, O’Connell JM, Kwasnik AK et al (2009b) Are natural killer cells protecting the metabolically healthy obese patient? Obesity 17:601–605PubMed
Zurück zum Zitat Ma J, Giovannucci E, Pollak M et al (2004) A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 96:546–553PubMed Ma J, Giovannucci E, Pollak M et al (2004) A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 96:546–553PubMed
Zurück zum Zitat Ma J, Li H, Giovannucci E et al (2008) Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 9:1039–1047PubMed Ma J, Li H, Giovannucci E et al (2008) Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 9:1039–1047PubMed
Zurück zum Zitat Macheda ML, Rogers S, Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202:654–662PubMed Macheda ML, Rogers S, Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202:654–662PubMed
Zurück zum Zitat Maes M, Meltzer HY, Stevens W et al (1994) Natural killer cell activity in major depression: relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology. Prog Neuropsychopharmacol Biol Psychiatry 18:717–730PubMed Maes M, Meltzer HY, Stevens W et al (1994) Natural killer cell activity in major depression: relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology. Prog Neuropsychopharmacol Biol Psychiatry 18:717–730PubMed
Zurück zum Zitat Mannucci E, Monami M, Balzi D et al (2010) Doses of insulin and its analogues and cancer occurence in insulin-treated type 2 diabetic patients. Diabetes Care 33:1997–2003PubMed Mannucci E, Monami M, Balzi D et al (2010) Doses of insulin and its analogues and cancer occurence in insulin-treated type 2 diabetic patients. Diabetes Care 33:1997–2003PubMed
Zurück zum Zitat Mathupala SP, Ko YH, Pedersen PL (2009) Hexokinase-2 bound to mitochondria: cancer’s stygian link to the “Warburg Effect” and a pivotal target for effective therapy. Semin Cancer Biol 19:17–24PubMed Mathupala SP, Ko YH, Pedersen PL (2009) Hexokinase-2 bound to mitochondria: cancer’s stygian link to the “Warburg Effect” and a pivotal target for effective therapy. Semin Cancer Biol 19:17–24PubMed
Zurück zum Zitat Mayer D, Chantelau E (2010) Treatment with insulin glargine (Lantus) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells. Arch Physiol Biochem 116:73–78PubMed Mayer D, Chantelau E (2010) Treatment with insulin glargine (Lantus) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells. Arch Physiol Biochem 116:73–78PubMed
Zurück zum Zitat Mazurek S, Boschek CB, Hugo F et al (2005) Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 15:300–308PubMed Mazurek S, Boschek CB, Hugo F et al (2005) Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 15:300–308PubMed
Zurück zum Zitat Mercer JC, Ragin MJ, August A (2005) Natural killer T cells: rapid responders controlling immunity and disease. Int J Biochem Cell Biol 37:1337–1343PubMed Mercer JC, Ragin MJ, August A (2005) Natural killer T cells: rapid responders controlling immunity and disease. Int J Biochem Cell Biol 37:1337–1343PubMed
Zurück zum Zitat Michaud DS, Wolpin B, Giovannucci E et al (2007) Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 16:2101–2109PubMed Michaud DS, Wolpin B, Giovannucci E et al (2007) Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 16:2101–2109PubMed
Zurück zum Zitat Montoya CJ, Pollard D, Martinson J et al (2007) Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 122:1–14PubMed Montoya CJ, Pollard D, Martinson J et al (2007) Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 122:1–14PubMed
Zurück zum Zitat Moorehead RA, Sanchez OH, Baldwin RM et al (2003) Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma. Oncogene 22:853–857PubMed Moorehead RA, Sanchez OH, Baldwin RM et al (2003) Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma. Oncogene 22:853–857PubMed
Zurück zum Zitat Moretta L, Bottino C, Pende D et al (2005) Human natural killer cells: molecular mechanisms controlling NK cell activation and tumor cell lysis. Immunol Lett 100:7–13PubMed Moretta L, Bottino C, Pende D et al (2005) Human natural killer cells: molecular mechanisms controlling NK cell activation and tumor cell lysis. Immunol Lett 100:7–13PubMed
Zurück zum Zitat Muller LM, Gorter KJ, Hak E et al (2005) Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 41:281–288PubMed Muller LM, Gorter KJ, Hak E et al (2005) Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 41:281–288PubMed
Zurück zum Zitat Nathan DM, Buse JB, Davidson MB et al (2009) Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32:193–203PubMed Nathan DM, Buse JB, Davidson MB et al (2009) Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32:193–203PubMed
Zurück zum Zitat O’Shea D, Cawood TJ, O’Farrelly C et al (2010) Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke. PLoS One 5:e8660PubMed O’Shea D, Cawood TJ, O’Farrelly C et al (2010) Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke. PLoS One 5:e8660PubMed
Zurück zum Zitat Pan SY, Johnson KC, Ugnat AM et al (2004) Association of obesity and cancer risk in Canada. Am J Epidemiol 159:259–268PubMed Pan SY, Johnson KC, Ugnat AM et al (2004) Association of obesity and cancer risk in Canada. Am J Epidemiol 159:259–268PubMed
Zurück zum Zitat Pedersen PL (2007) Warburg me and Hexokinase 2: multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr 39:211–222PubMed Pedersen PL (2007) Warburg me and Hexokinase 2: multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr 39:211–222PubMed
Zurück zum Zitat Pierce BL, Ahsan H (2010) Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk. Hum Hered 69:193–201PubMed Pierce BL, Ahsan H (2010) Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk. Hum Hered 69:193–201PubMed
Zurück zum Zitat Rapp K, Schroeder J, Klenk J et al (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49:945–952PubMed Rapp K, Schroeder J, Klenk J et al (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49:945–952PubMed
Zurück zum Zitat Reiche EM, Nunes SO, Morimoto HK (2004) Stress, depression, the immune system, and cancer. Lancet Oncol 5:617–625PubMed Reiche EM, Nunes SO, Morimoto HK (2004) Stress, depression, the immune system, and cancer. Lancet Oncol 5:617–625PubMed
Zurück zum Zitat Renehan AG, Zwahlen M, Minder C et al (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346–1353PubMed Renehan AG, Zwahlen M, Minder C et al (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346–1353PubMed
Zurück zum Zitat Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578PubMed Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578PubMed
Zurück zum Zitat Robey RB, Hay N (2006) Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 25:4683–4696PubMed Robey RB, Hay N (2006) Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 25:4683–4696PubMed
Zurück zum Zitat Robey RB, Hay N (2009) Is Akt the “Warburg kinase”?-Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol 19:25–31PubMed Robey RB, Hay N (2009) Is Akt the “Warburg kinase”?-Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol 19:25–31PubMed
Zurück zum Zitat Roddam AW, Allen NE, Appleby P et al (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149:461–471PubMed Roddam AW, Allen NE, Appleby P et al (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149:461–471PubMed
Zurück zum Zitat Roder JC, Kiessling R, Biberfeld P et al (1978) Target-effector interaction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing. J Immunol 121:2509–2517PubMed Roder JC, Kiessling R, Biberfeld P et al (1978) Target-effector interaction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing. J Immunol 121:2509–2517PubMed
Zurück zum Zitat Rosenstock J, Fonseca V, McGill JB et al (2009) Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study. Diabetologia 52:1971–1973PubMed Rosenstock J, Fonseca V, McGill JB et al (2009) Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study. Diabetologia 52:1971–1973PubMed
Zurück zum Zitat Rozengurt E, Sinnett-Smith J, Kisfalvi K (2010) Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer. Clin Cancer Res 16:2505–2511PubMed Rozengurt E, Sinnett-Smith J, Kisfalvi K (2010) Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer. Clin Cancer Res 16:2505–2511PubMed
Zurück zum Zitat Schäfer M, Werner S (2008) Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 9:628–638PubMed Schäfer M, Werner S (2008) Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 9:628–638PubMed
Zurück zum Zitat Schalkwijk CG, Stehouwer CD, van Hinsbergh VW (2004) Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification. Diabetes Metab Res Rev 20:369–382PubMed Schalkwijk CG, Stehouwer CD, van Hinsbergh VW (2004) Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification. Diabetes Metab Res Rev 20:369–382PubMed
Zurück zum Zitat Schoen RE, Tangen CM, Kuller LH et al (1999) Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91:1147–1154PubMed Schoen RE, Tangen CM, Kuller LH et al (1999) Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91:1147–1154PubMed
Zurück zum Zitat Schupp N, Schinzel R, Heidland A (2005) Genotoxicity of advanced glycation end products: involvement of oxidative stress and of angiotensin II type 1 receptors. Ann NY Acad Sci 1043:685–695PubMed Schupp N, Schinzel R, Heidland A (2005) Genotoxicity of advanced glycation end products: involvement of oxidative stress and of angiotensin II type 1 receptors. Ann NY Acad Sci 1043:685–695PubMed
Zurück zum Zitat Sciacca L, Cassarino MF, Genua M et al (2010) Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling. Diabetologia 53:1743–1753PubMed Sciacca L, Cassarino MF, Genua M et al (2010) Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling. Diabetologia 53:1743–1753PubMed
Zurück zum Zitat Sgambato A, Cittadini A (2010) Inflammation and cancer: a multifaceted link. Eur Rev Med Pharmacol Sci 14:263–268PubMed Sgambato A, Cittadini A (2010) Inflammation and cancer: a multifaceted link. Eur Rev Med Pharmacol Sci 14:263–268PubMed
Zurück zum Zitat Siekmeier R, Scheuch G (2008) Inhaled insulin—does it become reality? J Physiol Pharmacol 59(suppl 6):81–113PubMed Siekmeier R, Scheuch G (2008) Inhaled insulin—does it become reality? J Physiol Pharmacol 59(suppl 6):81–113PubMed
Zurück zum Zitat Sieradzki J (2005) Cukrzyca i zespół metaboliczny. In: Szczeklik A (ed) Choroby Wewnętrzne. Medycyna Praktyczna, Kraków, vol 1, pp 1179–1215 Sieradzki J (2005) Cukrzyca i zespół metaboliczny. In: Szczeklik A (ed) Choroby Wewnętrzne. Medycyna Praktyczna, Kraków, vol 1, pp 1179–1215
Zurück zum Zitat Smyth MJ, Thia KY, Street SE et al (2000) Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 191:661–668PubMed Smyth MJ, Thia KY, Street SE et al (2000) Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 191:661–668PubMed
Zurück zum Zitat Sparvero LJ, Asafu-Adjei D, Kang R et al (2009) RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 7:17PubMed Sparvero LJ, Asafu-Adjei D, Kang R et al (2009) RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 7:17PubMed
Zurück zum Zitat Spitz MR, Barnett MJ, Goodman GE et al (2002) Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Cancer Epidemiol Biomarkers Prev 11:1413–1418PubMed Spitz MR, Barnett MJ, Goodman GE et al (2002) Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Cancer Epidemiol Biomarkers Prev 11:1413–1418PubMed
Zurück zum Zitat Stattin P, Björ O, Ferrari P et al (2007) Prospective study of hyperglycemia and cancer risk. Diabetes Care 30:561–567PubMed Stattin P, Björ O, Ferrari P et al (2007) Prospective study of hyperglycemia and cancer risk. Diabetes Care 30:561–567PubMed
Zurück zum Zitat Stocks T, Lukanova A, Rinaldi S et al (2007) Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden. Int J Cancer 120:2678–2686PubMed Stocks T, Lukanova A, Rinaldi S et al (2007) Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden. Int J Cancer 120:2678–2686PubMed
Zurück zum Zitat Stocks T, Rapp K, Bjørge T et al (2009) Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med 6:e1000201PubMed Stocks T, Rapp K, Bjørge T et al (2009) Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med 6:e1000201PubMed
Zurück zum Zitat Stofkova A (2010) Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr Regul 44:25–36PubMed Stofkova A (2010) Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr Regul 44:25–36PubMed
Zurück zum Zitat Stopper H, Schinzel R, Sebekova K et al (2003) Genotoxicity of advanced glycation end products in mammalian cells. Cancer Lett 190:151–156PubMed Stopper H, Schinzel R, Sebekova K et al (2003) Genotoxicity of advanced glycation end products in mammalian cells. Cancer Lett 190:151–156PubMed
Zurück zum Zitat Swann JB, Uldrich AP, van Dommelen S et al (2009) Type I natural killer T cells suppress tumors caused by p53 loss in mice. Blood 113:6382–6385PubMed Swann JB, Uldrich AP, van Dommelen S et al (2009) Type I natural killer T cells suppress tumors caused by p53 loss in mice. Blood 113:6382–6385PubMed
Zurück zum Zitat Szkaradkiewicz A, Karpiński TM, Drews M et al (2010) Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-beta1) in patients with gastric cancer. J Biomed Biotechnol 2010:901564PubMed Szkaradkiewicz A, Karpiński TM, Drews M et al (2010) Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-beta1) in patients with gastric cancer. J Biomed Biotechnol 2010:901564PubMed
Zurück zum Zitat Takahashi K, Iwase M, Yamashita K et al (2001) The elevation of natural killer cell activity induced by laughter in a crossover designed study. Int J Mol Med 8:645–650PubMed Takahashi K, Iwase M, Yamashita K et al (2001) The elevation of natural killer cell activity induced by laughter in a crossover designed study. Int J Mol Med 8:645–650PubMed
Zurück zum Zitat Tappy L, Lê KA, Tran C et al (2010) Fructose and metabolic diseases: new findings, new questions. Nutrition 26:1044–1049PubMed Tappy L, Lê KA, Tran C et al (2010) Fructose and metabolic diseases: new findings, new questions. Nutrition 26:1044–1049PubMed
Zurück zum Zitat Trayhurn P, Wang B, Wood IS (2008) Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 100:227–235PubMed Trayhurn P, Wang B, Wood IS (2008) Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 100:227–235PubMed
Zurück zum Zitat Uribarri J, Cai W, Peppa M et al (2007) Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 62:427–433PubMed Uribarri J, Cai W, Peppa M et al (2007) Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 62:427–433PubMed
Zurück zum Zitat Uribarri J, Woodruff S, Goodman S et al (2010) Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 110:911–916.e12 Uribarri J, Woodruff S, Goodman S et al (2010) Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 110:911–916.e12
Zurück zum Zitat Velcheti V, Govindan R (2006) Insulin-like growth factor and lung cancer. J Thorac Oncol 1:607–610PubMed Velcheti V, Govindan R (2006) Insulin-like growth factor and lung cancer. J Thorac Oncol 1:607–610PubMed
Zurück zum Zitat Vella V, Pandini G, Sciacca L et al (2002) A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab 87:245–254PubMed Vella V, Pandini G, Sciacca L et al (2002) A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab 87:245–254PubMed
Zurück zum Zitat Vigneri P, Frasca F, Sciacca L et al (2009) Diabetes and cancer. Endocr Relat Cancer 16:1103–1123PubMed Vigneri P, Frasca F, Sciacca L et al (2009) Diabetes and cancer. Endocr Relat Cancer 16:1103–1123PubMed
Zurück zum Zitat Waldhauer I, Steinle A (2008) NK cells and cancer immunosurveillance. Oncogene 27:5932–5943PubMed Waldhauer I, Steinle A (2008) NK cells and cancer immunosurveillance. Oncogene 27:5932–5943PubMed
Zurück zum Zitat Warburg O (1956) On the origin of cancer cells. Science 123:309–314PubMed Warburg O (1956) On the origin of cancer cells. Science 123:309–314PubMed
Zurück zum Zitat Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519–530PubMed Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519–530PubMed
Zurück zum Zitat Waters KM, Henderson BE, Stram DO et al (2009) Association of diabetes with prostate cancer risk in the multiethnic cohort. Am J Epidemiol 169:937–945PubMed Waters KM, Henderson BE, Stram DO et al (2009) Association of diabetes with prostate cancer risk in the multiethnic cohort. Am J Epidemiol 169:937–945PubMed
Zurück zum Zitat Wei EK, Ma J, Pollak MN et al (2005) A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 14:850–855PubMed Wei EK, Ma J, Pollak MN et al (2005) A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 14:850–855PubMed
Zurück zum Zitat Werner H, Bruchim I (2009) The insulin-like growth factor-I receptor as an oncogene. Arch Physiol Biochem 115:58–71PubMed Werner H, Bruchim I (2009) The insulin-like growth factor-I receptor as an oncogene. Arch Physiol Biochem 115:58–71PubMed
Zurück zum Zitat Werner H, Le Roith D (2000) New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia. Cell Mol Life Sci 57:932–942PubMed Werner H, Le Roith D (2000) New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia. Cell Mol Life Sci 57:932–942PubMed
Zurück zum Zitat Werner H, Weinstein D, Bentov I (2008) Similarities and differences between insulin and IGF-I: structures, receptors, and signalling pathways. Arch Physiol Biochem 114:17–22PubMed Werner H, Weinstein D, Bentov I (2008) Similarities and differences between insulin and IGF-I: structures, receptors, and signalling pathways. Arch Physiol Biochem 114:17–22PubMed
Zurück zum Zitat Wolpin BM, Meyerhardt JA, Chan AT et al (2009) Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol 27:176–185PubMed Wolpin BM, Meyerhardt JA, Chan AT et al (2009) Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol 27:176–185PubMed
Zurück zum Zitat Wuenschell GE, Tamae D, Cercillieux A et al (2010) Mutagenic potential of DNA glycation: miscoding by (R)- and (S)-N2-(1-carboxyethyl)-2′-deoxyguanosine. Biochemistry 49:1814–1821PubMed Wuenschell GE, Tamae D, Cercillieux A et al (2010) Mutagenic potential of DNA glycation: miscoding by (R)- and (S)-N2-(1-carboxyethyl)-2′-deoxyguanosine. Biochemistry 49:1814–1821PubMed
Zurück zum Zitat Yamagishi S, Nakamura K, Inoue H et al (2005) Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients. Med Hypotheses 64:1208–1210PubMed Yamagishi S, Nakamura K, Inoue H et al (2005) Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients. Med Hypotheses 64:1208–1210PubMed
Zurück zum Zitat Yamagishi S, Matsui T, Nakamura K (2008) Possible involvement of tobacco-derived advanced glycation end products (AGEs) in an increased risk for developing cancers and cardiovascular disease in former smokers. Med Hypotheses 71:259–261PubMed Yamagishi S, Matsui T, Nakamura K (2008) Possible involvement of tobacco-derived advanced glycation end products (AGEs) in an increased risk for developing cancers and cardiovascular disease in former smokers. Med Hypotheses 71:259–261PubMed
Zurück zum Zitat Yan SF, D’Agati V, Schmidt AM et al (2007) Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging. Curr Mol Med 7:699–710PubMed Yan SF, D’Agati V, Schmidt AM et al (2007) Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging. Curr Mol Med 7:699–710PubMed
Zurück zum Zitat Yeluri S, Madhok B, Prasad KR et al (2009) Cancer’s craving for sugar: an opportunity for clinical exploitation. J Cancer Res Clin Oncol 135:867–877PubMed Yeluri S, Madhok B, Prasad KR et al (2009) Cancer’s craving for sugar: an opportunity for clinical exploitation. J Cancer Res Clin Oncol 135:867–877PubMed
Zurück zum Zitat Yi HK, Hwang PH, Yang DH et al (2001) Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells. Eur J Cancer 37:2257–2263PubMed Yi HK, Hwang PH, Yang DH et al (2001) Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells. Eur J Cancer 37:2257–2263PubMed
Zurück zum Zitat Zhou XH, Qiao Q, Zethelius B et al (2010) Diabetes, prediabetes and cancer mortality. Diabetologia 53:1867–1876PubMed Zhou XH, Qiao Q, Zethelius B et al (2010) Diabetes, prediabetes and cancer mortality. Diabetologia 53:1867–1876PubMed
Metadaten
Titel
Glucose Metabolism Disorders and the Risk of Cancer
verfasst von
Paweł Piątkiewicz
Anna Czech
Publikationsdatum
01.06.2011
Verlag
SP Birkhäuser Verlag Basel
Erschienen in
Archivum Immunologiae et Therapiae Experimentalis / Ausgabe 3/2011
Print ISSN: 0004-069X
Elektronische ISSN: 1661-4917
DOI
https://doi.org/10.1007/s00005-011-0119-0